(Q35012809)

5 August 2017

1 reference

title

Prostate cancer: another aspect of the insulin-resistance syndrome? (English)

1 reference

5 August 2017

1 reference

1 reference

1 reference

Barnard RJ

1

1 reference

5 August 2017

Aronson WJ

series ordinal

2

1 reference

5 August 2017

Tymchuk CN

series ordinal

3

1 reference

5 August 2017

Ngo TH

series ordinal

4

1 reference

5 August 2017

publication date

1 November 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

3

1 reference

5 August 2017

issue

4

1 reference

5 August 2017

page(s)

303-308

1 reference

The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00081.X

Reversibility of chronic experimental syndrome X by diet modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00081.X

Prostate cancer risk and serum levels of insulin and leptin: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00081.X

Reduced testosterone and adrenal C19 steroid levels in obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00081.X

Effects of a high-complex-carbohydrate, low-fat, low-cholesterol diet on levels of serum lipids and estradiol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00081.X

Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00081.X

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00081.X

Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00081.X

Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00081.X

Role of the insulin-like growth factor family in cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00081.X

Nutritional regulation of the insulin-like growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00081.X

Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00081.X

Does physical activity play a role in the prevention of prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00081.X

Diet and its preventive role in prostatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00081.X

Specific versus non-specific effects of dietary fat on carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00081.X

Insulin-like growth factor I induces MDM2-dependent degradation of p53 via the p38 MAPK pathway in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00081.X

Dietary trial in prostate cancer: Early experience and implications for clinical trial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00081.X

10.1046/J.1467-789X.2002.00081.X

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference